ProPhase Labs Acquires Digital Covid Vaccination and Testing “Passport” Solution
30 mars 2021 17h10 HE
|
ProPhase Labs, Inc.
New Reporting App Simplifies Documentation of User Vaccination and Covid Testing Statue – Easily Enables Clear Access to Air/Rail/Bus Travel, Concert & Sporting Events GARDEN CITY, NY, March...
ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time
15 mars 2021 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, March 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Wednesday, March 31, 2021...
ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up
01 févr. 2021 08h30 HE
|
ProPhase Labs, Inc.
Company to Host Business Update Shareholder’s Conference Call on February 10, 2021 at 11:00 a.m. Eastern Time GARDEN CITY, NY, Feb. 01, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:...
ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
29 janv. 2021 08h30 HE
|
ProPhase Labs, Inc.
- Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical...
ProPhase Labs, Inc. Announces Closing of Public Offering
21 janv. 2021 16h30 HE
|
ProPhase Labs, Inc.
Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced...
ProPhase Labs Announces Proposed Public Offering of Common Stock
15 janv. 2021 17h21 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has commenced a proposed...
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
05 janv. 2021 12h10 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive...
ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020
16 nov. 2020 08h30 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 16, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced net sales of $3.8 million for...
ProPhase Labs Completes Acquisition of CLIA Accredited Lab and Provides Corporate Update
02 nov. 2020 08h30 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has completed the...
ProPhase Labs Engages Industry Expert to Advise on Possible Acquisition of CLIA Accredited Labs Certified for COVID-19 and Other Testing
30 sept. 2020 17h04 HE
|
ProPhase Labs, Inc.
Company Enters into Consulting Agreement and Amended and Restated Promissory Note and Security Agreement with Predictive Laboratories, Inc. to Further These Plans DOYLESTOWN, Pennsylvania, Sept. 30,...